Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,916,619
in 9 filings, $5.9M under 10b5-1 plans

Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Sale −1,405 $45.23 $64K 48,374
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right To Buy) −1,000 $11.23 $11K 5,563
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right to Buy) −1,000 $11.23 $11K 4,563
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right To Buy) −1,100 $18.01 $20K 25,150
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right to Buy) −1,500 $18.01 $27K 23,650
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right to Buy) −1,800 $18.01 $32K 21,850
2021-07-08 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right to Buy) −1,405 $18.01 $25K 20,445
2021-06-11 Smith Mary L. Director Grant or award +1,650 1,650
2021-06-11 Smith Mary L. Director Grant or award +963 2,613
2021-06-11 Smith Mary L. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-11 Smith Mary L. Director Grant or award · Stock Option (Right to Buy) +5,834 5,834
2021-06-11 Peltz Stuart Walter Chief Executive Officer Grant or award +6,240 22,721
2021-06-11 Peltz Stuart Walter Chief Executive Officer Grant or award · Stock Option (Right to Buy) +36,400 36,400
2021-06-09 Svoronos Dawn Director Sale −365 $41.89 $15K 27,065
2021-04-20 Klein Matthew B. Chief Development Officer Sale −1,444 $46.58 $67K 17,006
2021-04-20 Klein Matthew B. Chief Development Officer Sale −197 $47.92 $9K 16,809
2021-04-19 Pauwels Eric Chief Business Officer Sale −786 $48.17 $38K 35,701
2021-04-19 Klein Matthew B. Chief Development Officer Sale −859 $48.17 $41K 18,450
2021-04-13 Peltz Stuart Walter Chief Executive Officer Grant or award +1,400 16,481
2021-02-08 Utter Christine Marie SVP, Finance & CAO Exercise or conversion +2,657 $33.02 $88K 19,166

Page 52 of 53 · 1,049 trades